In partnership with Convosphere, our teams together analysed the social media activity over ASCO 2018 from pharma, HCPs, experts and health organisations. To find out more from our findings, email thesocialcheckup@ogilvy.com
In partnership with Convosphere, our teams together analysed the social media activity over ASCO 2018 from pharma, HCPs, experts and health organisations. To find out more from our findings, email thesocialcheckup@ogilvy.com
2.
ASCO ANNUAL MEETING 2018
90,309 Total Tweets around
ASCO 2018 (1-5 June, 2018)
500 Million Potential Impressions
20,600 Unique Authors
19 Mil
26 Mil 32 Mil 42 Mil
97 Mil
21,043
23,151
21,657
13,190
11,268
June 1 June 2 June 3 June 4 June 5
Tweets per Day
Potential Reach per Day
We analyzed Twitter coverage of ASCO 2018
3.
TWITTER COVERAGE YEAR ON YEAR
2015 2016 2017
56,871
86,249
93,569 90,309
2018
Conversation has peaked and plateaued
4.
Note: Time frame considered: 1st – 5th June, 2018
HCP SHARE OF CONVERSATIONS
28%
35%
40% 40%
2015 2016 2017 2018
HCPs make up 40% of the Twitter users talking about ASCO
5.
Note: Time frame considered: 1st – 5th June, 2018
KEY STAKEHOLDER GROUPS
Media second greatest driver of conversation at ASCO 2018
6.
TOP AUTHORS AND MENTIONS
8,300
@ASCO
1,000
@GlopesMd
@montypal990
830
750 670 670
570 550 520@sloan_kettering
@MDAndersonNews
@DrChoueiri
@theNCI
@DanaFarber
@ASCOPres
@ConquerCancerFd
The top handles were mainly US cancer institutes
Note: Time frame considered: 1st – 5th June, 2018
7.
TAILORx
KEY TRIAL MENTIONS
Key trials discussed covered a range of different cancers
2,685
NCI / Breast Cancer
Research Foundation,
Komen Foundation
Breast
Cancer
CARMENA
1,418
Pfizer /
Assistance
Publique
Renal Cell
Carcinoma
KN 042
332
Merck & Co /
MSD
NSCLC
PRODIGE 7
148
UNICANCER
Colorectal
Cancer
CM 227
73
BMS
NSCLC
Note: Time frame considered: 1st – 5th June, 2018
Trial name:
Sponsored by:
8.
Note: Time frame considered: 1st – 5th June, 2018
KEY HASHTAGS
5,100 8,000
78,000
ASCO AWARENESS
1,500 1,700
2,200 2,400
3,700
4,100
5,300
DISEASE AWARENESS
Disease awareness hashtags were frequently used by those
talking about ASCO
9.
Based on share of total
cancer types mentioned
(~16,000 Tweets)
Based on share of total
cancer types mentioned
(~13,000 Tweets)
Brain 6%
Lung 29%
Breast 32%
Pancreas 2%
Skin 10%
Prostate 14%
2017
Colorectal 2%
KEY CANCER TOPICS DISCUSSED
Lung and breast cancer conversations dominated in 2017 & 2018
Brain 4%
Lung 34%
Breast 39%
Pancreas 7%
Skin 7%
Colorectal 4%
2018
Prostate 4%
Note: Time frame considered: 1st – 5th June, 2018
10.
Disease (Tumor Types)
Presentations/Sessions
Clinical Trials
Event Promotion
48%
12%
40%
28%
20%
Treatment
Technology
4%
Addition of key topics is more than 100% due to categorization of individual posts into multiple topics.
Note: Time frame considered: 1st – 5th June, 2018
KEY TOPICS OF DISCUSSION BY HCPS
Session and event promotion was the most frequently
discussed topic
11.
ConvoScore is a weighted Twitter channel performance score, based on overall engagement on Twitter
and engagement being driven by Pharma Company Twitter handles at ASCO 2018
50% 50%
Assigned weight on Overall Twitter
Performance:
Assigned weight on ASCO 2018
Engagement:
Overall Twitter Performance
Twitter Posts Follower Reach
ASCO 2018 Engagement
Posts around
ASCO ‘18
Engagement on Posts
around ASCO ’18
ConvoScore, is calculated by generating ratings based on key Twitter engagement and reach parameters which
is further rationalized to form a score between 20 to 100 with 100 being the most desirable score.
WE USED CONVOSCORE TO MEASURE
PHARMA COMPANY SOCIAL ENGAGEMENT
12.
75 65
65 60
ConvoScore is based on overall engagement on Twitter and performance of posts around ASCO 2018
TOP PHARMA COMPANIES RANKED AS
PER CONVOSCORE
13.
WHAT HAVE WE LEARNT?
Volume of Twitter
coverage at ASCO
has significantly
increased over the
past 3 years but
reduced slightly
since 2017
(93,569 in 2017 vs
90,309 in 2018)
HCPs had the
largest share of
conversation on
social media and
pharma only had
5% of
conversation share
The most engaged
with content
contained news-
worthy information
and very detailed
images
Although Amgen
was the most
mentioned pharma
company, Roche
was the top
company in terms
of engagement
14.
WHAT SHOULD PHARMA DO?
1.Control
content
pollution at
congress
15.
WHAT SHOULD PHARMA DO?
2.Understand
what content
types and
formats the
audience
wants
16.
WHAT SHOULD PHARMA DO?
3.Stay on top
of the latest
trends and
developments
in social
media
17.
CHLOE PARTIKAS
Social Director
Ogilvy Healthworld
REBECCA CANVIN
Director of Social Media
Ogilvy Healthworld
JACKIE CUYVERS
Chief Executive Officer
Convosphere
RICK EVANS
Senior Digital Strategist
Ogilvy Healthworld
info@convosphere.com
thesocialcheckup@ogilvy.com
CONTACT US
To find out more & discover
how our experts can enhance
social activity at congress
Convosphere: +44 (0)20 3858 0235
Ogilvy Healthworld: +44 (0)7770 331 436
Notas del editor
JACKIE: We collected this data, like previously and looked at …. You would expect to see conversations increase and peak in the middle of the congress before tailoring off.
On 3rd June, when most tweets mentioned ASCO, the Plenary Session was held (this includes abstract presentations of the top practice-changing science with commentary from expert discussants).
The number of people who attended ASCO in 2017 was 39,400 and whilst we don’t have the final figures for 2018 it looks like it was fairly similar We do know that there were many articles including one on Medscape about the fact that many HCPs are now not attending these big congresses in person due to a multitude of factors including cost, ecological concerns, availability etc The congress is becoming increasingly virtual and the organisers are looking to offer HCPs at home or in clinic as close as possible an experience to being there in person. Indeed we know that many of the leading influencers on social media at medical congresses are not actually present, but have the clout and reputation to drive the conversation online We also know that pharma companies have been criticised for putting so much paid media behind congress posts and dominating the conversation. This has been particulalrly negatively received by the HCP audience, in fact the audience the pharma companies are trying to reach most strongly Many pharma companies have held back more this year, and this might explain the slight drop-off of conversation We’ll discuss that in more detail later in this presentation
RICK: One of the conversations we always have with our clients is around how much HCPs actually use social media, and I think it’s fair to say that they are generally very busy people and not all of them have the time or inclination to use social media for professional purposes But this is changing, and we know that whilst not all HCPs are actively posting on social media, many more are following news sources and social media influencers At no times is this more apparent than during the big social media congresses such as ASCO Indeed, it’s really interesting to see that for the past few years 40% of all tweets about the congress were by HCPs, and that has increased quite dramatically from 2015 It could be that the plateau between 2017 and 2018 suggests that it has probably reached its peak so it will be interesting to see if the trend continues at the same level next year, especially as we know as not all HCPs are at the congress so the conversation is more online than offline at the event itself
RICK: Of course HCPs are not the only people talking about ASCO even if they make up the largest sector Healthcare and mainstream media predictably make up a significant percentage of the people talking about ASCO When we talk about experts here, we are talking about academics rather than active HCPs Organisations covers NGOs, government health organisations etc Pharma companies had quite a small share this year, quite possibly down to criticisms of the way they were higging the airwaves with paid promotion in previous years Communities looks at patient communities, blogs and forums Others includes posts we were unable to categorise
JACKIE: @ASCO we know @GLopesMD = cancer doctor and research @montypal = Physician/researcher interested in #kidneycancer @Sloankettering = Memorial Sloan Kettering Cancer Center @MDAnderson = cancer centre @DrChoueiri = oncologist GU cancers @DanaFarber cancer institute @theNCI = US National cancer institute @DanaFarber = cancer institute @ASCOpres = ASCO president @ConquerCancerFd = ASCO foundation
Takeaway- no surprises here for top authors & mentions
JACKIE: Here are the overall clinical trials discussed at ASCO
The TAILORx study. It dominated the headlines revealing that most women with a specific early-stage breast cancer and midrange score on the Oncotype Dx test do not need chemotherapy after surgery. These findings will spare thousands of women from the harmful effects of chemotherapy.
JACKIE: All well-established hashtags. No surprises – reflect the fact that breast cancer, lung cancer and immunotherapies were key congress topics.
JACKIE: Looking at 2018 ASCO abstracts (there are over 6,000 in total), and searching for the cancer types above, it follows a similar order as above:
Breast cancer (1187 abstracts) – 39% discussed on SoMe Lung cancer (1069) – 34% Colorectal (618) – 4% Prostate (392) 7% Skin (311) – 7% Pancreas (157) – 7% Brain (137) 4%
JACKIE: Awareness - Discussion around knowing or educating oneself or others around (a topic) ASCO, by spreading awareness through sharing of posts with details around the event per se, or on the presentations, sessions etc.. Clinical Trials: Posts on clinical trial results, on in general around a clinical trial, in ASCO related posts. Presentations/Sessions: Posts which mentioned of specific sessions, presentations etc., on clinical trials or on disease areas. Disease (Tumor Types): Posts which mentioned of any specific cancer types. Treatment: Posts which talked of treatment options for cancer. Technology: Posts on any tech by HCPs. Such as HCPs found "Twitter, Sync, iPlanner" making it easier to navigate the meetings.
JACKIE
JACKIE (Background: Switch in the top companies between Roche & Merck)
BECKY: The plateau of volume of ASCO conversation and that by HCPs on social media means that it has probably reached its peak. It will be interesting to see if the trend continues at the same level next year, especially as we know as not all HCPs are at the congress so the conversation is more online than offline at the event itself Highest engaged content at ASCO went against the guidance from social media companies of simple imagery Roche content received the highest engagement – simple tweets, informing people of their sessions, linking to a LinkedIn blog post and videos by the Global Head of Oncology stating her personal perspective on cancer treatments. Links to media releases.
BECKY: In recent years, during ASCO annual meetings, there’s been a growing concern raised by attendees and others engaging online that valuable conversations on social media may be overshadowed by content from pharma companies with large followings and more resources Astra Zeneca pledged to change their social media strategy at ASCO this year and laid out 5 points for its new social tactics, including a promise to talk less and listen more and stop paid advertising during congress. 5% of convos this year from pharma companies and poll from Mike Thompson revealed that 78% of people thought less pharma and less noise at ASCO So what should pharma do on social media at congress? Consider whether it’s valuable to be part of the conversation at congress and ensure you have a rationale for each piece of content – if you don’t have news then why are you being involved in the conversation? Might be useful to listen and understand the gaps instead. This will give you an opportunity to create more reactive content and be part of the conversation this way. If you have big data at a congress, the data will almost speak for itself and attendees will promote it on social media
BECKY: Although guidance from social platforms says in-stream images should be simple and uniform, it’s clear from our analysis that the best performing content had lots of information in the images. So what content formats should you use for your congress content? Choose your image based on who you're targeting. Depending on who you're targeting, whether by gender, age or another demographic, think about the types of images that will resonate. You may want to help your audience share your data by designing slides that are sized for twitter. Test a variety of images. No matter where you get your images from, always use a few variations of each so that you can test the images to see which one gets the best response.
BECKY: 1. Transparency is at the top of the social platforms agenda Social platforms are becoming more transparent following misuses of data On June 28, Facebook and Twitter both launched their transparency tools for advertising that will make all ads run on the platforms visible. These tools, which operate independently, mean an end to dark posts, far more access to information for consumers and for advertisers. Use this information to understand how posts are shared on social media at congress. 2. Take advantage of new formats – e.g. IG TV. Instagram recently announced that they have released a new app called IGTV that features full-screen, hour-long videos created by the accounts that you follow.
3. Embrace influencers but WISELY! Social media users are becoming much more savvy and less tolerant to influencers that endorse products too often Companies throw money at influencers and direct them to make content that undermines their authenticity Over time this threatens to disrupt the opportunity for everyone We need to embrace influencer marketing with new methods and new forms of creativity
Los recortes son una forma práctica de recopilar diapositivas importantes para volver a ellas más tarde. Ahora puedes personalizar el nombre de un tablero de recortes para guardar tus recortes.
Crear un tablero de recortes
Compartir esta SlideShare
¿Odia los anuncios?
Consiga SlideShare sin anuncios
Acceda a millones de presentaciones, documentos, libros electrónicos, audiolibros, revistas y mucho más. Todos ellos sin anuncios.
Oferta especial para lectores de SlideShare
Solo para ti: Prueba exclusiva de 60 días con acceso a la mayor biblioteca digital del mundo.
La familia SlideShare crece. Disfruta de acceso a millones de libros electrónicos, audiolibros, revistas y mucho más de Scribd.
Parece que tiene un bloqueador de anuncios ejecutándose. Poniendo SlideShare en la lista blanca de su bloqueador de anuncios, está apoyando a nuestra comunidad de creadores de contenidos.
¿Odia los anuncios?
Hemos actualizado nuestra política de privacidad.
Hemos actualizado su política de privacidad para cumplir con las cambiantes normativas de privacidad internacionales y para ofrecerle información sobre las limitadas formas en las que utilizamos sus datos.
Puede leer los detalles a continuación. Al aceptar, usted acepta la política de privacidad actualizada.